News

Heart failure affects 64 million people worldwide and many cases remain undetected and/or untreated despite available evidence-based therapies. AI can help tackle this problem with 100% automated disease detection. Join us in Prague at Heart Failure 2023 in the Roche booth for live demonstrations of AI automated echo for the detection of heart failure. Automation…

Transthyretin (ATTR) amyloidosis is emerging as an under recognized form of heart failure especially in the elderly.  The aim of the study was to assess the ability of Us2.ai to assess prognosis, in this patient population, at the University College London National Amyloidosis Centre, the largest center worldwide for cardiac amylodosis. “With Us2.ai software, in a little more than…

In the US and Europe, Mitral Regurgitation (MR) is the most common valvular heart disease.  It is very difficult to grade MR, but extremely important because the more severe the MR is, the worse the prognosis for patients. Unfortunately, using echocardiograms and other modalities to grade MR they is very cumbersome, lengthy and inaccurate.  AI could…

Strain imaging is currently the most sensitive parameter reflecting myocardial deformation and systolic left ventricular function.  Reduced left ventricular global longitudinal strain (GLS) predicts adverse events, as well as helps diagnose myocardial diseases and monitor sub-clinical myocardial disease progression. We analyzed myocardial global longitudinal strain in three different cohorts. Fully automated measurements of GLS and…

Heart failure will be very prevalent in the future where 1 in 10 people above the age of 65 will be diagnosed with heart failure.  However, access to professionally perform echocardiograms can have wait times of 4 to 6 months which delays treatment of heart failure.  Perhaps we could train novices with no prior sonography…

AI echo at EACVI 2023 – join us in Barcelona to learn more about echo analysis software. Scientific ValidationAmyloidosis – 10 May (9:30 AM), Moderated ePosters 2Automated analysis of echocardiograms can predict prognosis in ATTR cardiomyopathy Adam Ioannou, National Amyloidosis Centre, University College London, Royal Free Hospital Strain – 10 May (11:30 AM), Teatro Scientifico…

AI POCUS – AI Point-of-Care Ultrasound Heart Screening by Novices in The PANES HF Study New Orleans, LA, March 01, 2023 – (PR.com) – Novice laypersons with no prior experience underwent two-weeks training to acquire echo images among individuals with suspected heart failure using point-of-care ultrasound combined with AI-based image analysis, disease detection and reporting from…

Echo analysis software for AI decision support – a YouTube interview describing how machine learning can democratize healthcare with automated AI echo disease detection

AI echo FDA-cleared echo analysis software to process full echo reports with zero clicks in under 2 minutes SINGAPORE – (BUSINESS WIRE) – Us2.ai, a Singapore-based medtech firm backed by IHH Healthcare, Heal Partners and Sequoia India will provide AI software that assists in analyzing research echocardiograms or heart ultrasounds to Brigham and Women’s Hospital’s Cardiac…

7 Incredible Things I Saw at HLTH2022: Las Vegas. What Happened In Vegas Definitely Won’t Stay There